Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials

Norrby, M; Vesikari, T; Lindqvist, L; Maeurer, M; Ahmed, R; Mandavifar, S; Bennett, S; McClain, JB; Shepherd, BM; Li, D; Hokey, DA; Kromann, I; Hoff, ST; Andersen, P; de Visser, AW; Joosten, SA; Ottenhoff, THM; Andersson, J; Brighenti, S

Brighenti, S (reprint author), Karolinska Inst, Karolinska Univ Hosp Huddinge, CIM, Dept Med Huddinge, S-14186 Stockholm, Sweden.

VACCINE, 2017; 35 (12): 1652

Abstract

Background: Novel vaccine strategies are required to provide protective immunity in tuberculosis (TB) and prevent development of active disease. We in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索